For reference, tesamorelin's FDA label dose alone is 2 mg/day (or 1.28 mg/day for the EGRIFTA WR formulation), and ipamorelin has been studied around 100-300 mcg per dose
GHK-Cu supports recovery by activating repair-related genes, regulating inflammation, promoting collagen and elastin production, and improving blood vessel formation
All these properties have been confirmed by clinical studies
Injectable GHK-Cu is less documented in the scientific literature and requires more clinical studies to determine its safety and effectiveness
Glutathione has been utilized in the treatment of various conditions such as Parkinson's disease, Alzheimer's disease, cancer, and HIV/AIDS
Your haematologist will advise on how long you need to keep taking the injections